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Abstract
Background: Although impacts upon gastric cancer incidence of race, age, sex, and Lauren type
have been individually explored, neither their importance when evaluated together nor the
presence or absence of interactions among them have not been fully described.
Methods: This study, derived from SEER (Surveillance, Epidemiology, and End Results (SEER)
Program of the National Cancer Institute) data, analyzed the incidences of gastric cancer between
the years 1992–2001. There were 7882 patients who had developed gastric cancer. The total
denominator population was 145,155, 669 persons (68,395,787 for 1992–1996, 78,759,882 for
1997–2001). Patients with multiple tumors were evaluated as per the default of the SEER*Stat
program. 160 age-, five year period (1992–1996 vs 1997–2001)-, sex-, race (Asian vs non-Asian)-,
Lauren type- specific incidences were derived to form the stratified sample evaluated by linear
regression. (160 groups = 2 five year periods × 2 race groups × 2 sexes × 2 Lauren types × 10 age
groups.) Linear regression was used to analyze the importance of each of these explanatory
variables and to see if there were interactions among the explanatory variables.
Results: Race, sex, age group, and Lauren type were found to be important explanatory variables,
as were interactions between Lauren type and each of the other important explanatory variables.
In the final model, the contribution of each explanatory variable was highly statistically significant (t
> 5, d.f. 151, P < 0.00001). The regression equation for Lauren type 1 had different coefficients for
the explanatory variables Race, Sex, and Age, than did the regression equation for Lauren type 2.
Conclusion: The change of the incidence of stomach cancer with respect to age for Lauren type
1 stomach cancer differs from that for Lauren type 2 stomach cancers. The relationships between
age and Lauren type do not differ across gender or race. The results support the notion that Lauren
type 1 and Lauren type 2 gastric cancers have different etiologies and different patterns of
progression from pre-cancer to cancer. The results should be validated by evaluation of other
databases.
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Background
Worldwide, the stomach is the second most common site
of origin of cancer [1]. Although an array of histologic
classifications is in use, that proposed by Lauren [2],
retains its durability because its two types have been the
most widely compared and because pathologists can
reproducibly distinguish Lauren type 1 from Lauren type
2 cancers [3]. Year of diagnosis [4-15], gender [5,12,16-
25], race [22,26-33], age [10,13,14,16,18,19,21,24,26,35-
38], and Lauren type [5,11,18,19,26,27,35,39-41], have
all been found by recent epidemiologic studies to be
important explanatory variables for stomach cancer inci-
dence; various interactions among these variables have
also been demonstrated [5,10-14,16,19,22,24,35]. We
hypothesized that, by examining a large database, it might
be possible to evaluate each of the above factors and inter-
actions among the factors to explain differences in stom-
ach cancer incidence.
The Surveillance, Epidemiology, and End Results (SEER)
Program of the National Cancer Institute is an authorita-
tive source of information on cancer incidence and sur-
vival in the United States that currently collects and
publishes cancer incidence and survival data from 14 pop-
ulation-based cancer registries and three supplemental
registries covering approximately 26 percent of the US
population; the SEER website provides extensive informa-
tion about it [42].
The study used SEER to evaluate the contributions of age,
sex, race (Asian vs non-Asian), year of diagnosis (1992–
1996 vs 1997–2001), and Lauren type to gastric cancer
incidence. The study showed Lauren type 1 tumor inci-
dence increased with respect to age in a different way than
did Lauren type 2 tumor incidence; the regression equa-
tions that described these relations were the same for men
and women and for Asians and non-Asians. Incidence was
considered in terms of the natural logarithms of the rates
of development, over a five year period, of stomach can-
cer.
Methods
Data acquisition
The SEER data base, SEER 11 Regs + AK Public-Use, Nov
2003 Sub for Expanded Races (1992–2001) was used
[44]. The analysis was limited to persons with stomach
cancer 40 years and older. The SEER*STAT program strat-
ified persons who developed stomach cancer and the
underlying population from which they emanated, into
ten age groups, two sexes, two races, two Lauren types, and
two five year periods. This produced two numbers for
each of 160 age, race, sex, Lauren type, and five year
period groups, a number of persons who developed stom-
ach cancer and an underlying number of persons in the
denominator. Lauren type 1 was defined as those patients
whose cancers showed intestinal morphology (M-8144);
Lauren type 2 was defined as those patients whose cancers
showed diffuse (M-8145), signet ring cell (M-8490), or
linitis plastica (M-8142) morphology. The ten age groups
were defined as follows: 40–44 (group 1), 45–49 (group
2), 50–54 (group 3), 55–59 (group 4), 60–64 (group 5),
65–69 (group 6), 70–74 (group 7), 75–79 (group 8), 80–
84 (group 9), and 85+ (group 10). The relative lack of
blacks who had stomach cancer meant many analyzed
cells would be zero, making the analysis suspect. The two
races evaluated were Asian and non-Asian. Persons of
unknown race were excluded. Multiple primaries were
handled by the default set by the SEER*STAT program.
The two five-year periods comprised the years 1992–1996
and 1997–2001. Table 1 schematizes the data acquisition.
Hence, SEER generated 160 numbers pairs. Each pair
comprised a number of persons who developed stomach
cancer and a number of persons in the denominator. For
each set a rate was calculated by dividing the number of
persons with stomach cancer by the number of persons in
the denominator. For example, from 1992–1996, 35 Lau-
ren type 1 stomach cancers were observed among
2,752,873 non-Asian men ages 40–44: the rate was 1.27 ×
10-5. From 1997–2001, of 366,766 Asian women aged
65–69, 55 developed Lauren type 1 gastric cancer: the rate
was 1.60 × 10-4.
Statistical methods
Software
R was used for data analysis.
Data transformation
Counts and population provided by SEER*STAT were
used to calculate rates. Preliminary data analysis showed
the distribution of rates lacked a normal distribution. One
cell had no persons with cancer; to take the natural loga-
rithms of rates in a circumstance in which a zero cell is
present, one may increase for all cells the numerator and
the denominator by 0.5 [44]:
ln(ca) = ln [(persons with cancer + 0.5)/(persons in
denominator + 0.5)]
Model selection
All models tested were linear regression models with the
response variable being the logarithms of the cancer rates,
as defined above. Analysis of variance determined which
model best reflected the data. Covariates were always
added to regression; the ratio of the change in the residual
sum of squares (∆RSS) to the RSS before the covariate was
added was compared with an F test. Independent (explan-
atory or predictor) variables included: A) Five year period
(1992–1996 = 0, 1997–2001 = 1), B) Sex (men = 0,
women = 1), C) Race (Non Asian = 0, Asian = 1), D) Lau-BMC Cancer 2006, 6:65 http://www.biomedcentral.com/1471-2407/6/65
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ren type (type 1 = 0, type 2 = 1), E) Age Group (40–44 =
1, 45–49 = 2, 50–54 = 3, etc.). All ten possible two-way
variable interactions were assessed. The null hypothesis
was rejected if P < 0.05. Neither higher-order explanatory
variable interactions nor non-linear relationships of
explanatory variables to the response variable were con-
sidered in this analysis.
Evaluation of the data precluded the performance of Pois-
son regression: the mean number of patients with cancer
was 49; the variance was 2224. When Poisson regression
was tried with population as an offset, with or without the
zero cell, all five potential explanatory variables (five year
period, sex, race, Lauren type, and age) and all ten poten-
tial first order interactions were associated with the
counts; each explanatory variable had an associated z >
600, P < 1 × 10-10. A residual plot showed the model
lacked a good fit.
Model adequacy
Standardized residuals were calculated by R. To test the
assumption that the standardized residuals were normally
distributed, a Shapiro-Wilks test was performed. To test
the assumption that the mean of the standardized residu-
als was 0, a t-test was performed. To test the assumption
that the standardized residuals had constant variance with
Table 1: Schema for acquisition of data from SEER for this study.
DATA 
STATISTIC 
Statistic: Crude Rates
SELECTION 
Case Only: {Site and Morphology.Site recode} = 'Stomach'
Option: Select only malignant behaviour
TABLE 
Row: Year of dx, 92–96, 97–01 [Year of diagnosis]
Men and Women [Sex]
Stomach cancer types [Histologic Type ICD-O-3]
Race, Asian or not, no unknown [Race recode Y]
Column: Age recode with <1 year olds
USER DEFINITIONS 
Stomach cancer types [Histologic Type ICD-O-3]
intestinal = 8144
non-intestinal = 8142,8145,8490
Year of dx, 92–96, 97–01 [Year of diagnosis]
1992–1996 = 1992, 1993, 1994, 1995, 1996
1997–2001 = 1997, 1998, 1999, 2000, 2001
Sex [Sex]
Male = Male
Female = Female
Race, Asian or not, no unknown [Race recode Y]
Asian = Asian or Pacific Islander
Non-Asian = All other except unknown
Table 2: Frequency distribution of 7882 persons who developed stomach cancer, by five year period, by sex, by race, and by Lauren 
type.
five year period 1992–1996 1997–2001
3,429 4,453
Sex Men women
4,399 3,483
Race Asian non-Asian
2,059 5,823
Lauren type type 1 Type 2
1,992 5,890BMC Cancer 2006, 6:65 http://www.biomedcentral.com/1471-2407/6/65
Page 4 of 13
(page number not for citation purposes)
respect to the fitted values, the standardized residuals
were divided into quartiles and Bartlett's test for homoge-
neity of variances was performed. A data point was con-
sidered an outlier if its studentized residual, calculated by
R, was greater than 3; dffits (a measure which gives greater
weight to outlying observations) and Cook's distance (a
measure of impact of the respective case on the regression
equation), calculated by R were used to assess leverage;
outliers that are found to have high leverage, large dffits
and/or Cook's distances, are considered bad leverage
points and are removed from the analysis.
Results
Raw data
The distribution of persons who developed cancer, strati-
fied by Lauren type, five year period, sex, and race, is dis-
played in Table 2. The distribution of the denominator
population, stratified by five year period, sex, and race, is
shown in Table 3. Age group distributions for the persons
who developed cancer and the denominator population
are displayed in Table 4.
Summary of model building
Initial evaluation showed rates lacked a normal distribu-
tion (Shapiro-Wilks W = 0.76, P < 0.0001). As discussed
in the model adequacy section, the use of the logarithms
of the rates yielded a model that fulfilled the assumptions
of linear regression, once an outlier was removed; the
residuals of that model did not prove to lack a normal dis-
tribution, did not have a mean that proved to differ from
zero, and did not prove to lack homogeneity of variance.
Table 5 displays the results of the univariate analyses. Sig-
nificant associations between the natural logarithms of
cancer rates and age group, race, Lauren type, and sex, but
not five year period, were identified. Table 6 displays the
results, with and without the outlier identified at model
adequacy assessment, of ANOVA comparisons of sequen-
tial models; the results confirmed those of the univariate
analyses. Table 7 displays the results of the analysis of
interaction covariates. ANOVA demonstrated significant
decreases in residual sum of squares when interactions of
Lauren type and age group, Lauren type and race, and Lau-
ren type and sex were added to regression. No other first
order interaction was shown by ANOVA to decrease RSS
sufficiently to reject the null hypothesis.
Final model
The final model did not include five year period as an
explanatory variable because 1) there was no association
between the natural logarithms of the cancer rates and the
five year period and 2) there was no demonstrated inter-
action between five year period and any other explanatory
variable. The final model, displayed in Table 8, included
the four other main effects (ME) covariates and the four
interaction covariates found to significantly reduce resid-
ual sum of squares (RSS). Lauren type interacted with the
group of explanatory variables that include Race, Age, and
Sex, which did not interact with one another. Hence, Lau-
ren type 1 and type 2 cancers differ as regards the shapes
of the age distributions, sex, and race. When Lauren type
Table 3: Frequency distribution of denominator population by five year period, by sex, and by race.
five year period 1992–1996 1997–2001
68,395,787 76,759,882
Sex men women
67,831,186 77,324,483
Race Asian non-Asian
14,600,067 130,555,602
Table 4: Frequency distribution of persons with cancer and persons in denominator by age group.
Ages Persons with Cancer Persons in Denominator
40–44 353 4.5% 29,331,208 20.2%
45–49 442 5.6% 25,218,817 17.4%
50–54 542 6.9% 20,412,681 14.1%
55–59 631 8.0% 15,655,389 10.8%
60–64 762 9.7% 13,042,756 9.0%
65–69 1,056 13.4% 11,913,627 8.2%
70–74 1,250 15.9% 10,623,230 7.3%
75–79 1,203 15.3% 8,522,907 5.9%
80–84 874 11.1% 5,660,379 3.9%
85+ 769 9.8% 4,774,675 3.3%
Total 7,882 100.0% 145,155,669 100.0%BMC Cancer 2006, 6:65 http://www.biomedcentral.com/1471-2407/6/65
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is taken into account, similar statements cannot be made
for differently-aged patients, for men and women, for the
five year periods 1992–1996 and 1997–2001, and for
Asians and non-Asians.
Two regression equations, using the values for the final
model without the outlier, express the results:
Lauren type 1
ln(ca) = -14.15 - 1.07 × sex + 1.74 × race + 0.52 × age
group
Lauren type 2
ln(ca) = -11.55 - 0.23 × sex + 0.97 × race + 0.28 × age
group
For the above equations:
• ln(ca) is the response variable, the natural logarithm of
the stomach cancer rates.
• Sex, Race, and Age are explanatory variables (sometimes
called risk factors)
• The numbers in front of the explanatory variables are
called regression coefficients or beta weights. Coefficients
are interpreted as follows: if Sex and Age are held constant
(or "controlling for" Sex and Age), then, for Lauren type 1
Table 5: Univariate regression of the natural logarithm of the rate of stomach cancer on five year period, on sex, on race, on Lauren 
type, and on age group.
Explanatory 
variable
Intercept R2 Estimate Std Error t Pr (> | t|)
five year period -10.40 0.002 0.16 0.26 0.61 0.54
Sex -9.98 0.042 -0.68 0.26 -2.62 0.01
Race -11.01 0.174 1.38 0.24 5.77 4.1 × 10-8
Lauren type -10.98 0.158 1.31 0.24 5.44 2.0 × 10-7
age group -12.54 0.491 0.40 0.03 12.35 < 1 × 10 -10
Table 6: Comparisons of linear regression models, with and without outlier, of the natural logarithm of the rate of stomach cancer on 
the main explanatory variables. The difference between the residual sum of squares (RSS) before and after each explanatory variable 
had been added to regression (∆RSS) was divided by RSS and multiplied by the error df to yield F, whose numerator df was 1 and 
denominator df was the error df.
WITHOUT OUTLIER
Model Covariates RSS ∆RSS error df F P
Null 403.26
five year period 402.96 0.30 157 0.1 0.73
five year period + sex 388.32 14.64 156 5.9 0.02
five year period +sex 
+ race
319.23 69.09 155 33.5 3.8 × 10-8
five year period + sex 
+ race + Lauren type
255.93 63.30 154 38.1 5.7 × 10-9
five year period + sex 
+ race + Lauren type 
+ age
50.64 205.29 153 620.2 < 1 × 10 -10
WITH OUTLIER
Model Covariates RSS ∆RSS error df F P
Null 437.81
five year period 436.79 1.02 158 0.4 0.54
five year period + sex 418.50 18.29 157 6.9 0.01
five year period +sex 
+ race
342.38 76.12 156 34.7 2.3 × 10-8
five year period + sex 
+ race + Lauren type
273.23 69.15 155 39.2 3.5 × 10-9
five year period + sex 
+ race + Lauren type 
+ age
58.14 215.10 154 569.8 < 1 × 10 -10BMC Cancer 2006, 6:65 http://www.biomedcentral.com/1471-2407/6/65
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stomach cancer, mean ln(ca) increases by about 1.74 if
the group is Asian; for Lauren type 2 stomach cancer, the
corresponding increase is 0.97.
Figures 1, 2, 3 and 4 plot predicted and observed loga-
rithms of stomach cancer rates versus age comparing
Asian and non-Asian men and Asian and non-Asian
women. Actual data confirms the regression equations:
data points pretty closely approximate the lines in all
cases. Although the races and sexes may start off with dif-
ferent incidences at age 40, changes in incidence with
respect to age are quite similar. Because the incidence of
patients with Lauren type 1 tumors 1) starts out lower
than and 2) rises at almost twice the rate of the incidence
of patients with Lauren type 2 tumors, the ratio of Lauren
type 1 to type 2 incidences strongly depends on age. Com-
pare Asian and non-Asian men: at age 40 both groups
show a greater incidence of patients who developed Lau-
ren type 2 tumors; at age 85 Asians show a greater inci-
dence of patients who developed Lauren type 1 tumors,
which is not true for non-Asians.
Model adequacy
There was only one outlier, a data point with a studen-
tized residual over 3. No non-Asian women, aged 45–49
years, developed Lauren type 1 stomach cancer; it was the
only zero cell. The studentized residual, -5.40, corre-
sponded with the largest Cook's distance, 0.183, and the
dffit, -1.316, with the largest absolute value. The outlier
was a bad leverage point. Although results for the outlier
are displayed in the tables, the high leverage meant that
the outlier should be excluded from the final analysis.
Table 7: Comparisons of linear regression models, with and without outlier, of the natural logarithm of the rate of stomach cancer on 
the main explanatory variables and each of ten interaction variables. The main effects (ME) comprised the explanatory variables five 
year period, sex, race, Lauren type, and age. The difference between the residual sum of squares (RSS) before and after the addition of 
each interaction variable to ME (∆RSS) was divided by RSS and multiplied by error d.f. to yield F, whose numerator df was 1 and 
denominator df was error df.
WITHOUT OUTLIER
Model Covariates RSS ∆RSS error df F P
ME 50.64
ME + five year 
period:sex
50.60 0.05 152 0.1 0.71
ME + five year 
period:race
50.09 0.55 152 1.7 0.20
ME + five year period: 
Lauren type
50.51 0.13 152 0.4 0.53
ME + five year 
period:age
50.04 0.60 152 1.8 0.18
ME + sex:race 50.62 0.02 152 0.1 0.82
ME + sex:Lauren type 43.99 6.65 152 23.0 3.9 × 10-6
ME + sex:age 50.63 0.02 152 0.0 0.83
ME + race:Lauren type 45.00 5.64 152 19.0 2.3 × 10-5
ME + race:age 49.50 1.14 152 3.5 0.06
ME + Lauren type:age 31.62 19.03 152 91.5 < 1 × 10 -10
WITH OUTLIER
Model Covariates RSS ∆RSS error df F P
ME 58.14
ME + five year 
period:sex
57.95 0.19 153 0.5 0.48
ME + five year 
period:race
57.22 0.92 153 2.5 0.12
ME + five year period: 
Lauren type
57.80 0.34 153 0.9 0.35
ME + five year 
period:age
57.88 0.25 153 0.7 0.41
ME + sex:race 58.01 0.13 153 0.3 0.57
ME + sex:Lauren type 50.34 7.79 153 23.7 2.8 × 10-6
ME + sex:age 58.11 0.02 153 0.1 0.81
ME + race:Lauren type 51.44 6.70 153 19.9 1.6 × 10-5
ME + race:age 57.50 0.63 153 1.7 0.20
ME + Lauren type:age 36.88 21.25 153 88.2 < 1 × 10 -10BMC Cancer 2006, 6:65 http://www.biomedcentral.com/1471-2407/6/65
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Removing the outlier yielded the same choice of covari-
ates.
Quantitative assessments of model adequacy are dis-
played in Table 9. The final model with the outlier had a
set of standardized residuals with non-constant variance,
when evaluated by Bartlett's test; the model without the
outlier did not show this failure of model assumption.
The final model with the outlier had a set of standardized
residuals without a normal distribution, when evaluated
by the Shapiro-Wilks test; the model without the outlier
did not show this failure of model assumption. Neither
the model with nor the model without the outlier had
standardized residuals whose means differed from zero,
Table 8: Final multiple linear regression models, with and without outlier, of the natural logarithm of the rate of stomach cancer.
WITHOUT 
OUTLIER
Parameter Estimate Std Error t df Pr(>| t|) 95% Conf Int
Intercept -14.15 0.11 -134.44 151 < 1 × 10 -10 -14.35 – -13.94
Sex -1.07 0.08 -13.15 151 < 1 × 10 -10 -1.23 – -0.91
Race 1.74 0.08 21.42 151 < 1 × 10 -10 1.58 – 1.90
Lauren type 2.59 0.15 17.53 151 < 1 × 10 -10 2.30 – 2.89
Age 0.52 0.01 36.69 151 < 1 × 10 -10 0.49 – 0.55
age:Lauren type -0.24 0.02 -12.19 151 < 1 × 10 -10 -0.28 – -0.20
race:Lauren type -0.77 0.11 -6.72 151 3.6 × 10 -10 -0.99 – -0.54
sex:Lauren type 0.83 0.11 7.28 151 < 1 × 10 -10 0.61 – 1.06
Overall Model Std Error R2 Fd f  n u m d f  d e nP
0.36 0.95 421 7 151 < 1 × 10 -10
WITH OUTLIER
Parameter Estimate Std Error t df Pr(>| t|) 95% Conf Int
Intercept -14.23 0.11 -125.58 152 < 1 × 10 -10 -14.45 – -14.01
Sex -1.12 0.09 -12.73 152 < 1 × 10 -10 -1.29 – -0.94
Race 1.79 0.09 20.38 152 < 1 × 10 -10 1.62 – 1.96
Lauren type 2.68 0.16 16.71 152 < 1 × 10 -10 2.36 – 2.99
Age 0.53 0.02 34.72 152 < 1 × 10 -10 0.50 – 0.56
age:Lauren type -0.25 0.02 -11.74 152 < 1 × 10 -10 -0.30 – -0.21
race:Lauren type -0.82 0.12 -6.59 152 6.7 × 10 -10 -1.06 – -0.57
sex:Lauren type 0.88 0.12 7.11 152 < 1 × 10 -10 0.64 – 1.13
Overall Model Std Error R2 Fd f  n u m d f  d e nP
0.39 0.95 384 7 152 < 1 × 10 -10
Table 9: Quantitative assessments of model adequacy.
Shapiro-Wilks normality test performed on standardized residuals.
WP
Without outlier 0.984 0.06
With outlier 0.960 0.0001
T test to see if mean of standardized residuals was not zero.
Mean T df P
Without outlier -0.003 -0.03 158 0.97
With outlier -0.003 -0.03 159 0.97
Bartlett's test to see if the standardized residuals, divided into four groups by their corresponding fitted values, lacked constant variances.
K2 Df P
Without outlier 4.43 3 0.22
With outlier 15.02 3 0.002BMC Cancer 2006, 6:65 http://www.biomedcentral.com/1471-2407/6/65
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when evaluated by a t test. Variable inflation factor analy-
sis showed no problems with multicollinearity among the
main explanatory variables.
Discussion
This study found, in the SEER database, that Lauren type
1 and Lauren type 2 stomach cancers differ to such a
degree that different regression equations are required to
explain variations in their incidences. Sex, race (Asian or
non-Asian), and age are explanatory variables, but the
equations that relate these explanatory variables to the
incidence of each Lauren type differ. Recent epidemio-
logic studies well support the rationale of the current
study, namely to evaluate year of diagnosis (in this case
five year period), sex, race, age and Lauren type. The arti-
cles also support the need for evaluation of interactions
and also provide interesting thoughts about the limita-
tions of administrative databases and other factors that
should be considered in future studies.
Year of diagnosis
Boyle [4] found stomach cancer in general was declining
in incidence in Europe, as did Faycal [5], Pineros [6] in
Columbia, Ardanaz [7] in Navarro, and Stracci [8] and
Crocetti [9] in Italy. Liu's [10] results showed that over
time, for both sexes, there were different trends for stom-
ach cancer depending on the third of the stomach
involved and the age of the patient. Henson [11] studied
Lauren type 2 and Lauren type 1 incidences over time,
revealing that the changes over time differed between the
two Lauren types. Sunny's [12] study of Indian men and
women revealed different rates of decline in stomach can-
cer, demonstrating an interaction of time of diagnosis and
sex. Levi [13], using joinpoint regression analysis, found
Plot of the natural logarithms of cancer rates, denoted as ln(ca), as a function of age in years for Asian men Figure 1
Plot of the natural logarithms of cancer rates, denoted as ln(ca), as a function of age in years for Asian men. Red references 
Lauren type 1 gastric cancer. Blue references Lauren type 2 gastric cancer. Lines represent predicted values. [see Additional file 
1]
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that the fall over time in gastric cancer rates was propor-
tionally greater for older than for younger persons,
although all showed a decline. The results of the study of
Kobayashi [14], by contrast, gave the lion share of the dec-
rement in gastric cancer for the young. For the Greenland
Inuit, stomach cancer rates appear to have increased [15].
This study of SEER data did not show time of diagnosis or
an interaction of any factor and time of diagnosis to be an
important explanatory variable for the incidence of stom-
ach cancer over the decade 1992–2001 in the United
States.
Sex
Marmo [16], Turkdogan [17], Faycal [5], Bani-Hanu [21],
and Dobru [18] all showed men at greater risk for stom-
ach cancer than women. Among Epstein Barr Virus posi-
tive cancers, the gender difference exists, but is only
statistically significant for Lauren type 2 gastric cancers
[19]. A family history of stomach cancer would appear to
place women, but not men at increased risk [20]. Alaskan
Native American men differ less from other American
men than do Alaskan Native American women, demon-
strating an interaction of sex and race [22]. Green tea con-
sumption appears to protect women, but not men, from
gastric cancer [23]. Japanese men appear to have a greater
increase in risk as they age than do Japanese women [24].
Khan [25] found that different foods for men than for
women increased the risk of gastric cancer. This study of
SEER data identified gender as an important explanatory
variable for the incidence of stomach cancer.
Race
Ciliated metaplasia, a precursor to stomach cancer, occurs
at different rates in the Pacific and Atlantic basins [26].
Plot of the natural logarithms of cancer rates, denoted as ln(ca), as a function of age in years for Asian women Figure 2
Plot of the natural logarithms of cancer rates, denoted as ln(ca), as a function of age in years for Asian women. Red references 
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Yao [27] showed that Hispanics with stomach cancer dif-
fered in age than other persons and that Asians differed in
survival than other persons. Multiple studies have placed
Asians at greater risk of gastric cancer [28-30]. When a
known risk factor, such as H. pylori, becomes universally
acquired, it ceases to be a risk factor; this has been shown
to have occurred in Koirea [31]. This study of SEER data
did not find an interaction between race and sex, but did
identify race as an explanatory variable for stomach cancer
incidence.
As to black race, some have suggested that Caucasians are
more likely than blacks to develop gastric cancer that
arises in the cardia and that blacks are more likely than
Caucasians to develop gastric cancer that arises outside
the cardia [32,33]. There were insufficient patients in this
study to subdivide the analysis by site within the stomach
or to separately analyze black persons. To evaluate the
importance of black race, studies would need 1) to have
more black patients and 2) to take into account whether
the cancer originated in the gastric cardia or not. The loca-
tion of origin would be of interest in itself as immunohis-
tochemical patterns of cardia and non-cardia gastric
cancers differ [34].
Age
Older persons more likely develop ciliated metaplasia
than do young persons [26]. Multiple studies have shown
that age is a vitally important factor to consider as regards
the risk of stomach cancer [18,35,21]. In terms of other
risk factors, there is good reason to think that H pylori's
effect declines with age [36] and that acquisition of H
pylori after age 1 may be less important in carcinogenesis
than is acquisition before age 1 [37]. Marmo [16] and
Plot of the natural logarithms of cancer rates, denoted as ln(ca), as a function of age in years for non-Asian men Figure 3
Plot of the natural logarithms of cancer rates, denoted as ln(ca), as a function of age in years for non-Asian men. Red references 
Lauren type 1 gastric cancer. Blue references Lauren type 2 gastric cancer. Lines represent predicted values. [see Additional file 
1]
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Tanaka [24] demonstrated an interaction of age and sex.
Levi [13], Kobayashi [14], and Liu [10] showed an inter-
action of age and time of diagnosis. A prior study [38] sug-
gested that the effect of environmental carcinogens is
largely limited to childhood. The latter is in accord with
our study, which would suggest that a person's risk of can-
cer is set at or below the age of 40 and that its expression
occurs at predictable increments thereafter. This study of
SEER data found age to be an explanatory variable for
stomach cancer incidence.
Lauren type
Loss of CDX2 may represent a marker of tumor progres-
sion in early gastric cancer and carcinomas with an intes-
tinal, but not a non-intestinal phenotype [39]. The
frequency of ciliated metaplasia differs between intestinal
and non-intestinal stomach cancer types [26]. For some
nations, Lauren type 1 cancer was more common than
Lauren type 2 [18,40]. Yao [27] showed Hispanics differed
in Lauren type from other persons. An interaction with
between time of diagnosis and Lauren type exists [5,11].
van Beek [41] found that Epstein Barr Virus associated
cancer was more frequently associated with Lauren type 1
than with Lauren type 2 adenocarcinoma. This study of
SEER data found interactions of Lauren type and race, age,
and gender to be of such importance that two different
regression equations had to be created to describe the
data. The importance of separating Lauren types from one
another lies in part in the demonstrated multiple interac-
tions between Lauren type and so many other variables,
both those found in this study and those found in recent
epidemiologic studies.
Plot of the natural logarithms of cancer rates, denoted as ln(ca), as a function of age in years for non-Asian women Figure 4
Plot of the natural logarithms of cancer rates, denoted as ln(ca), as a function of age in years for non-Asian women. Red refer-
ences Lauren type 1 gastric cancer. Blue references Lauren type 2 gastric cancer. Lines represent predicted values. [see Addi-
tional file 1]
Red is Lauren type 1.  Blue is Lauren type 2.
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The above discourse allows one to appreciate the limita-
tions and utility of the study. SEER is, like many of the
sources of the other studies, an administrative database.
Administrative databases lack a review of histopathology;
the added loss of precision is unavoidable because such a
review would increase the expense of any such study and
decrease participation by hospitals, largely invalidating its
results. As expected, specific program codes are not avail-
able on line for investigators, reviewers, readers, and edi-
tors to explore issues that may be important to them, such
as the means of creation of a denominator in rate calcula-
tions. The website is excellent, but might also include
readily accessible links to the data registries themselves
and their policies and procedures, so investigators, review-
ers, editors, and readers can satisfy any questions they
might have as to such matters as data collection or the par-
ticular manner of dealing with multiple primaries for a
particular study. No administrative database can keep a
record of such things as H pylori rates, genetic markers,
food intake, or any of the other above miscellaneous fac-
tors identified. As with any study, the number of factors
that can be evaluated is limited both for reasons of data
collection and for statistical reasons having to do with
sample size; for this reason, a global explanation encom-
passing all potential factors cannot be expected. The most
any epidemiologic study can offer is a partial explanation
of complex phenomena. Most vital, the above referenced
recent studies show that any conclusion derived by exam-
ination of a particular population must be verified by
evaluation of multiple populations. This is because factors
that are important in one population may be unimpor-
tant in another population; only by repeating an analysis
in multiple populations can an epidemiologic conclusion
be considered verified. Notwithstanding these caveats,
such studies of epidemiology have great practical signifi-
cance; Marmo [16] used such results to design a screening
protocol for stomach cancer based on age and sex so as to
reduce cost.
Conclusion
In summary, two regression equations were derived from
the SEER database to explain differences in stomach can-
cer incidence, one for Lauren type 1 stomach cancers, one
for Lauren type 2 stomach cancers. Each regression equa-
tion revealed a simple relationship between the natural
logarithm of stomach cancer incidence rates and age.
These equations were the same for men and women and
for Asians and non-Asians. These results should be veri-
fied by similar evaluations conducted in other popula-
tions.
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